1. Home
  2. NYXH vs ACV Comparison

NYXH vs ACV Comparison

Compare NYXH & ACV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NYXH
  • ACV
  • Stock Information
  • Founded
  • NYXH 2009
  • ACV 2015
  • Country
  • NYXH Belgium
  • ACV United States
  • Employees
  • NYXH N/A
  • ACV N/A
  • Industry
  • NYXH Medical/Dental Instruments
  • ACV Finance/Investors Services
  • Sector
  • NYXH Health Care
  • ACV Finance
  • Exchange
  • NYXH Nasdaq
  • ACV Nasdaq
  • Market Cap
  • NYXH 261.1M
  • ACV 236.7M
  • IPO Year
  • NYXH 2021
  • ACV N/A
  • Fundamental
  • Price
  • NYXH $7.85
  • ACV $22.32
  • Analyst Decision
  • NYXH Strong Buy
  • ACV
  • Analyst Count
  • NYXH 5
  • ACV 0
  • Target Price
  • NYXH $17.00
  • ACV N/A
  • AVG Volume (30 Days)
  • NYXH 37.4K
  • ACV 38.8K
  • Earning Date
  • NYXH 11-06-2024
  • ACV 01-01-0001
  • Dividend Yield
  • NYXH N/A
  • ACV 9.20%
  • EPS Growth
  • NYXH N/A
  • ACV N/A
  • EPS
  • NYXH N/A
  • ACV N/A
  • Revenue
  • NYXH $5,668,079.00
  • ACV N/A
  • Revenue This Year
  • NYXH $37.10
  • ACV N/A
  • Revenue Next Year
  • NYXH $418.12
  • ACV N/A
  • P/E Ratio
  • NYXH N/A
  • ACV N/A
  • Revenue Growth
  • NYXH 32.65
  • ACV N/A
  • 52 Week Low
  • NYXH $4.00
  • ACV $16.82
  • 52 Week High
  • NYXH $20.00
  • ACV $23.74
  • Technical
  • Relative Strength Index (RSI)
  • NYXH 42.46
  • ACV 53.02
  • Support Level
  • NYXH $7.86
  • ACV $22.50
  • Resistance Level
  • NYXH $8.81
  • ACV $23.39
  • Average True Range (ATR)
  • NYXH 0.46
  • ACV 0.27
  • MACD
  • NYXH 0.06
  • ACV -0.07
  • Stochastic Oscillator
  • NYXH 43.87
  • ACV 13.97

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest

Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It seeks to achieve its investment objective by investing in a combination of convertible securities, debt and other income-producing instruments and common stocks and other equity securities.

Share on Social Networks: